Skip to main content

Posts

Showing posts from May, 2018
Breast and cervical cancer rates rising globally Breast and cervical malignancy could surpass maternal mortality as a reason for death in younger ladies in the developing world. Around 2 million women are developing breast or cervical cancer every year, according to the first global review, which warns that the sicknesses could overwhelm maternal mortality as a reason for death in more youthful ladies. Much of the increase in cancer rates are in low-income countries. The thing is about to worry is that the breast cancer is rising in younger women of reproductive age, between 15 and 49. As high-salary nations appreciate the advantage of early disease screenings, sedate treatments, and antibodies, the weight of breast and cervical growth is moving to low-wage nations in Africa and Asia. Inside those nations, more ladies are treating breast and cervical growth amid their regenerative years, including more weight families and social orders officially experiencing high
Breast cancer vaccine on its way? Not quite yet… Today’s front page of The Mirror tells the story of a ‘breast cancer vaccine’ that could be used to treat triple negative breast cancer and save thousands of lives. The idea is an exciting one, but in reality, the research behind the story is still a long way from benefiting patients. Read on to find out more about the work and what Breast Cancer Now is doing in this area. Tackling triple negative To determine what type of breast cancer a person has, doctors test for three ‘markers’: Oestrogen receptor (ER), progesterone receptor (PR), and multiple copies of the gene HER2. Triple-negative breast cancer , as the name suggests, lacks these three markers, and makes up about 15% of all new breast cancer cases, roughly 7,500 women every year. Unfortunately, unlike other types of breast cancer, there are no targeted treatments available for triple negative breast cancer. This means to treat triple-negative tumours, which can
Genomic medicine for secondary breast cancer: hype or reality? For some, it’s the next great step forward in secondary breast cancer treatment. For others, the benefits simply aren’t clear enough. In a hospital clinic, somewhere in the UK, someone awaits the news they never want to hear. “I’m afraid your cancer has returned, and it has spread. The best thing we can do is start treatment right away”. Unfortunately, this is an all too familiar scene for the thousands of people currently living with secondary breast cancer, and one that can feel like a death sentence. For many of these patients, treatments are ineffective, toxic and in many cases, only serve to extend life rather than cure their disease. The only reassuring part of the news is that there are treatments available.  Chemotherapy  is the weapon of choice against most secondary cancers, but using it can be like trying to hit a bullseye with a shotgun.  For all the guidance and evidence there is for picking the b
What Affects Intimacy & Satisfaction after Prophylactic Mastectomy & Breast Reconstruction Hello boys and girls. Today we’re going to discuss mastectomies and breast reconstruction. Definition: A mastectomy is a surgery that removes the whole or as much of the breast tissue as possible. There are different types of mastectomies, but basically, the purpose of a mastectomy is to remove the cancerous breast from the body in order to prevent the spread of cancer to other parts of the body. It is (in my understanding) a life-saving measure. With growing knowledge of genetic mutations and their association with an increased risk of breast cancer, more women are choosing to undergo risk-reducing mastectomy and breast reconstruction. This growing trend led researchers to examine what factors influence a patient’s intimate life and overall satisfaction with their breast reconstruction outcomes. Choosing to undergo a prophylactic mastectomy is a major life-c